Tnf LLC Sells 1,062 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Tnf LLC reduced its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 9.1% in the second quarter, Holdings Channel reports. The fund owned 10,616 shares of the real estate investment trust’s stock after selling 1,062 shares during the quarter. Tnf LLC’s holdings in Sabra Health Care REIT were worth $176,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of SBRA. Norges Bank acquired a new stake in Sabra Health Care REIT in the fourth quarter worth about $31,605,000. Natixis acquired a new position in Sabra Health Care REIT during the first quarter worth $633,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Sabra Health Care REIT by 63.6% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 318,808 shares of the real estate investment trust’s stock worth $4,709,000 after buying an additional 123,966 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Sabra Health Care REIT by 2.3% in the 4th quarter. Principal Financial Group Inc. now owns 21,487,279 shares of the real estate investment trust’s stock valued at $306,623,000 after purchasing an additional 484,086 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of Sabra Health Care REIT by 170.2% in the 4th quarter. Russell Investments Group Ltd. now owns 399,215 shares of the real estate investment trust’s stock valued at $5,697,000 after purchasing an additional 251,482 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA traded up $0.47 during trading on Friday, hitting $16.63. The company had a trading volume of 2,810,777 shares, compared to its average volume of 2,046,812. The business’s 50-day moving average is $15.86 and its 200 day moving average is $14.74. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.27 and a current ratio of 4.27. The company has a market cap of $3.85 billion, a P/E ratio of 83.15, a PEG ratio of 2.34 and a beta of 1.24. Sabra Health Care REIT, Inc. has a 52 week low of $12.00 and a 52 week high of $16.94.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last released its earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). The company had revenue of $176.14 million during the quarter, compared to analysts’ expectations of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The firm’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.34 EPS. Equities research analysts predict that Sabra Health Care REIT, Inc. will post 1.37 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Monday, August 19th will be given a $0.30 dividend. The ex-dividend date of this dividend is Monday, August 19th. This represents a $1.20 annualized dividend and a yield of 7.22%. Sabra Health Care REIT’s dividend payout ratio is 600.00%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Scotiabank upped their price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 15th. Truist Financial increased their price objective on Sabra Health Care REIT from $15.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, June 27th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus price target of $16.40.

Get Our Latest Stock Report on SBRA

About Sabra Health Care REIT

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

See Also

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.